Skip to Content

461 (Carbidopa and levodopa extended release 25 mg / 100 mg)

Pill with imprint 461 is Beige, Elliptical / Oval and has been identified as Carbidopa and levodopa extended release 25 mg / 100 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 461

Carbidopa and levodopa extended release

Imprint:
461
Strength:
25 mg / 100 mg
Color:
Beige
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
62756-0461

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide